Product Pipeline

Preclinical

Phase 1

Phase 2

Phase 3

Approved

for Focal Onset Seizures (FOS)
X-TOLE2/3 Clinical Trial

for Primary Generalized Tonic-Clonic Seizures (PGTCS)
X-ACKT Clinical Trial

for Major Depressive Disorder (MDD)
X-NOVA Clinical trial

for MDD
Investigator-led Phase 2 POC study Collaboration with Mount Sinai

for Rare Pediatric Epilepsy: SCN8A-DEE
Partnered with Neurocrine Biosciences

for Focal-Onset Seizures in Adults
Partnered with Neurocrine Biosciences

Learn more about our ongoing clinical trials

View Medical Affairs

See publications related to our clinical development candidates

View Publications

Find out more about collaborating with Xenon

View Partners